NCT02861755 Online Positive Emotion Skills Intervention for Symptoms of Depression Status COMPLETED Phase NA
NCT02861040 Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Status WITHDRAWN Phase PHASE1
NCT02854657 Teaching Skin Self -Examination to Melanoma Patients and Their Skin Check Partners Status COMPLETED Phase NA
NCT02847559 Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma Status RECRUITING Phase PHASE2
NCT02846662 Effectiveness of a Mobile Technology Intervention for the Treatment of Depression Status COMPLETED Phase PHASE3
NCT02841787 Online Peer Networked Collaborative Learning for Managing Depressive Symptoms Status COMPLETED Phase NA
NCT02840799 Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF) Status COMPLETED Phase PHASE2
NCT02837029 Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer Status COMPLETED Phase PHASE1
NCT02836522 Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL) Status COMPLETED Phase N/A
NCT02820753 A Universal Medication Schedule to Promote Adherence to Complex Drug Regimens Status COMPLETED Phase NA
NCT02820168 Designing a Programming Language for Patient-Oriented Prescriptions Status COMPLETED Phase N/A
NCT02819804 Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE1
NCT02810704 Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement Status COMPLETED Phase PHASE4
NCT02808143 Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer Status COMPLETED Phase PHASE1
NCT02805868 Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis Status WITHDRAWN Phase EARLY_PHASE1
NCT02801877 IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression Status COMPLETED Phase NA